These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10350336)

  • 1. Expression of CD44 isoforms on isolated bone marrow plasma cells and peripheral CD19+ B cells of patients with multiple myeloma and healthy individuals.
    Schuster-Kolbe J; Ludwig H; Adolf GR; Heider KH
    Leuk Lymphoma; 1999 Jun; 34(1-2):95-103. PubMed ID: 10350336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease.
    van Driel M; Günthert U; Stauder R; Joling P; Lokhorst HM; Bloem AC
    Leukemia; 1998 Nov; 12(11):1821-8. PubMed ID: 9823960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells.
    Van Driel M; Günthert U; van Kessel AC; Joling P; Stauder R; Lokhorst HM; Bloem AC
    Leukemia; 2002 Jan; 16(1):135-43. PubMed ID: 11840273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
    Bendall LJ; Bradstock KF; Gottlieb DJ
    Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion of multiple myeloma peripheral blood B cells to bone marrow fibroblasts: a requirement for CD44 and alpha4beta7.
    Masellis-Smith A; Belch AR; Mant MJ; Pilarski LM
    Cancer Res; 1997 Mar; 57(5):930-6. PubMed ID: 9041197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
    Kryworuckho M; Diaz-Mitoma F; Kumar A
    Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44 variants in osteosarcoma.
    Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression.
    Khaldoyanidi S; Achtnich M; Hehlmann R; Zöller M
    Leuk Res; 1996 Oct; 20(10):839-51. PubMed ID: 8960109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response.
    Demyanets S; Kaider A; Simonitsch-Klupp I; Bayer G; Subasic A; Thalhammer R; Esterbauer H; Krauth MT; Agis H; Reiter T; Schwarzinger I
    Ann Hematol; 2020 Nov; 99(11):2599-2609. PubMed ID: 32935190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.
    Paiva B; Pérez-Andrés M; Vídriales MB; Almeida J; de las Heras N; Mateos MV; López-Corral L; Gutiérrez NC; Blanco J; Oriol A; Hernández MT; de Arriba F; de Coca AG; Terol MJ; de la Rubia J; González Y; Martín A; Sureda A; Schmidt-Hieber M; Schmitz A; Johnsen HE; Lahuerta JJ; Bladé J; San-Miguel JF; Orfao A; ;
    Leukemia; 2011 Apr; 25(4):697-706. PubMed ID: 21252988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
    Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
    Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
    Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
    Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma.
    Stauder R; Van Driel M; Schwärzler C; Thaler J; Lokhorst HM; Kreuser ED; Bloem AC; Günthert U; Eisterer W
    Blood; 1996 Oct; 88(8):3101-8. PubMed ID: 8874209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential therapeutic biomarkers in plasma cell myeloma: a flow cytometry study.
    Zheng W; Liu D; Fan X; Powers L; Goswami M; Hu Y; Lin P; Medeiros LJ; Wang SA
    Cytometry B Clin Cytom; 2013; 84(4):222-8. PubMed ID: 23450831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
    Ghazi-Visser L; Laman JD; Nagel S; van Meurs M; van Riel D; Tzankov A; Frank S; Adams H; Wolk K; Terracciano L; Melief MJ; Sabat R; Günthert U
    FASEB J; 2013 Sep; 27(9):3683-701. PubMed ID: 23752202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD19 expression and growth inhibition of tumours in human multiple myeloma.
    Ishikawa H; Tsuyama N; Mahmoud MS; Fujii R; Abroun S; Liu S; Li FJ; Kawano MM
    Leuk Lymphoma; 2002 Mar; 43(3):613-6. PubMed ID: 12002767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients.
    Hosen N; Matsuoka Y; Kishida S; Nakata J; Mizutani Y; Hasegawa K; Mugitani A; Ichihara H; Aoyama Y; Nishida S; Tsuboi A; Fujiki F; Tatsumi N; Nakajima H; Hino M; Kimura T; Yata K; Abe M; Oka Y; Oji Y; Kumanogoh A; Sugiyama H
    Leukemia; 2012 Sep; 26(9):2135-41. PubMed ID: 22430638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.